Using video capsule endoscopy to find gastrointestinal bleeding in the small bowel

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study investigates the effectiveness of small bowel capsule endoscopy as a diagnostic tool for detecting gastrointestinal bleeding that has not been identified through traditional methods like gastroscopy and colonoscopy. It includes both prospective and retrospective cohorts to assess the detection rates of bleeding and the outcomes of subsequent endoscopic treatments. The study aims to evaluate the timing of the capsule endoscopy in relation to the onset of bleeding, as well as to document findings related to tumors, vascular issues, and inflammation. Additionally, it will track complications and the accessibility of the cecum during procedures.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* suspicion of gastrointestinal bleeding in the small bowel undetected by gastroscopy and colonoscopy
* informed consent

Exclusion Criteria:

* contraindications for small bowel capsule endoscopy (e.g. stenosis)

Where it's running

• University Medical Center Freiburg, Department of Medicine II
  Freiburg im Breisgau, Germany Recruiting

Study contacts

• Principal investigator: Michael Schultheiss, MD — University Medical Center Freiburg, Department of Medicine II, Freiburg, Germany
• Study coordinator: Michael Schultheiss, MD
• Email: michael.schultheiss@uniklinik-freiburg.de
• Phone: +49761/270-34010

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Endovascular treatment outcomes after portal hypertension–related GI bleeding in cirrhosis

  This study tests how well endovascular procedures for portal hypertension–related GI bleeding work in adults with cirrhosis, and what factors predict outcomes.

  Recruiting University Medical Center Ho Chi Minh City (UMC) · Ho Chi Minh City · NCT07918378

• Tegoprazan to prevent GI complications in ischemic stroke patients on antiplatelet therapy

  This trial tests whether tegoprazan can lower gastrointestinal complications in adults with ischemic stroke or TIA who are starting antiplatelet therapy.

  Recruiting at 24 sites Phase 3 Hanyang University · Busan, Busan and 23 other locations · NCT07687706

• Routine use of Potassium Competitive Acid Blocker vs guideline GI protection in AMI with PCI

  This trial tests whether giving a potassium competitive acid blocker regularly after AMI with PCI and DAPT helps more than following standard GI protection guidelines.

  Recruiting Phase 3 Samsung Medical Center · Seoul · NCT07467213

• Managing gastrointestinal bleeding in people taking direct oral anticoagulants

  This project will see how doctors treat gastrointestinal bleeding in adults on direct oral anticoagulants and whether giving prothrombin complex concentrate (PCC) appears helpful and safe.

  Recruiting University Hospital, Strasbourg, France · Strasbourg · NCT07333144

• Wireless optical capsule to detect upper gastrointestinal bleeding

  This trial will test a swallowed wireless optical capsule (HemoPill) to see if it can detect bleeding in adults with suspected upper gastrointestinal bleeding.

  Recruiting Chinese University of Hong Kong · Shatin, Hong Kong Island · NCT06715293

• Using physiological parameters to predict outcomes in cirrhotic patients with gastrointestinal bleeding

  This study is testing if certain health measurements can help doctors predict how well patients with liver cirrhosis and gastrointestinal bleeding will do, so they can provide better emergency care.

  Recruiting St. Martin De Porress Hospital · Tainan · NCT06680583

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.